Katholieke Universiteit Te Leuven
- Address
- Herestraat 49, 3000 Leuven, Belgium
Female Urogenital Diseases & Pregnancy Complications
The department at Katholieke Universiteit Te Leuven concentrates on maternal health, exploring ways to lower the risk of preterm preeclampsia and improve outcomes for high‑risk pregnancies.
- Prevention of preeclampsia in twin pregnancies
- Effect of low-dose aspirin on delivery timing
- Strategies to manage pregnancy complications in women with urogenital disorders
With three investigators and commercial collaboration, the site advances evidence‑based care for expectant mothers across Europe.
Nervous System Diseases
Research in the neuro‑degenerative field targets amyotrophic lateral sclerosis, testing innovative therapies to assess safety and patient tolerability.
- Evaluation of novel compounds for ALS treatment
- Safety profiling of multi‑ascending dose regimens
- Open‑label extension studies to monitor long‑term effects
The university’s clinical unit, supported by commercial partners, conducts cutting‑edge trials to expand therapeutic options for individuals with nervous system disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Katholieke Universiteit Te Leuven
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Acetylsalicylic Acid Versus Placebo for Preeclampsia Prevention in Twin Pregnancies: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial | Fundacion Para La Formacion E Investigacion Sanitaria De La Region De Murcia | Phase III | Recruiting | Mar 2023 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Acetylsalicylic Acid | 1 | Unknown | 2023-03-23 | 2023-03-23 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.